← Back to calculator

Current regulator label

Semaglutide

Semaglutide

A neutral reference on semaglutide: its GLP-1 mechanism, FDA-approved prescription status, once-weekly subcutaneous route, and common vial sizes, so you understand the drug before using our separate dosage calculator for the math.

Peptide Calculator X

Reconstitution / draw volume / syringe units / supply-chain

Arithmetic + reference toolNot medical advice
Inputs
Approved label
Product form
Target dose
Weight unit
Syringe barrel
Draw to
50units
0.5 mL5 mg/mL2.5 mg / dose
1 mL syringe - 100 u/mLFits
50 u050100 u
ARITHMETIC OK - VERIFY CLINICALLY

Arithmetic checks out. Confirm clinically, against the label, and against the actual vial before any use.

10 mg
4
0 mg
28 days
-
-

Independent check - dose mg / concentration mg/mL = volume. U-100 units = mL x 100.

Reconstitution planner

Reverse: pick a dose and the units you want it to read, then calculate diluent to add.

Reverse
Desired dose
1 mL
10 mg/mL
4
Formula and source context only. Not medical advice; verify with a clinician, product label, pharmacist, or approved research protocol. Do not use this tool to infer sterility, potency, purity, stability, compatibility, or an appropriate dose. Catalog and supply-chain data: finnrick.com/products - research date 2026-06-24.

Semaglutide: reference record

Semaglutide - regulatory status, route, frequency and published range
Regulatory statusFDA-approved prescription for labeled indications
RouteSubcutaneous
Dosing frequencyOnce weekly
Published range0.25–2.4 mg
Evidence basisCurrent regulator label
Common vial sizes5, 10, 30

Sources

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist, a synthetic peptide that mimics a gut hormone involved in blood-sugar regulation and appetite. It is the active ingredient in prescription products for type 2 diabetes and chronic weight management, and it also exists in an oral tablet form on a different dosing scale.

Is Semaglutide FDA-approved?

Yes. Semaglutide is FDA-approved as a prescription medicine for its labeled indications, and the reference figures here come from the current FDA label. That approval applies to the licensed products, not to compounded or research-grade powder sold under the same name.

How is Semaglutide given?

The licensed injectable is given subcutaneously, once weekly. Commercial pens are supplied pre-filled at a labeled concentration. Oral semaglutide is a separate product on an entirely different scale and cannot be converted to an injectable amount.

What are the known safety concerns with Semaglutide?

It is prescription-only. A critical distinction: oral semaglutide uses different dosing from the injectable and must never be converted between the two. Indication, contraindications and monitoring belong with a prescriber.

Wegovy: 0.25 mg weekly weeks 1-4, then 0.5, 1.0, 1.7; usual maintenance 2.4 mg

Commercial Wegovy is prefilled. Use only the labeled concentration or pharmacy directions.

Prescription-only; oral semaglutide uses different dosing and must not be converted with this injectable calculator.

Supply-chain quality · Finnrick

Avg quality score

6.9

/10

Purity range

98.34

99.99

%

Qty divergence

±

38

%

Vendors · samples

52

·

315

Common vial sizes

5, 10, 30

mg

Test window

Dec 2024 - May 2026

Related calculators & comparisons

Browse all peptides →